Company family
Gland: medicine shortages
As of 2 Nov 2026, 23 Gland products have a reported shortage across 1 countries, covering 7 medicines.
Products short23rank #94 of 464
Medicines7active ingredients
Countries1/16
New in 90 days00 vs market pace
Typical duration6.6 yearsmedian so far
Manufacturing56%demand-driven 22%
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
Latest changes
All changesNo changes recorded yet. Changes are tracked from our daily snapshots.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
Download CSV| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Furosemide | 6 | 7 Apr 2020 | Not stated | 11/16 | |
| Ketorolac | 5 | 23 Mar 2018 | Not stated | 4/16 | |
| Carboplatin | 4 | 28 Apr 2023 | Increased demand | 10/16 | |
| Dexmedetomidine | 3 | 10 Apr 2020 | Not stated | 4/16 | |
| Etomidate | 2 | 5 Oct 2022 | Not stated | 3/16 | |
| Midazolam | 2 | 2 Apr 2020 | Other | 7/16 | |
| Metronidazole | 1 | 13 Jan 2022 | Manufacturing problem | 1/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.